Paper Review Records
All Paper Review Records
22 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
206
days
Beyond borders: advancing oncology trials
Authors
Milit S. Patel; Jeffrey Shi Kai Chan; Nina N. Sanford; Jonas Willmann; Puneeth Iyengar; Edward Christopher DeeShow moreShow less
Affiliations
1. Department of Molecular Biosciences, The University of Texas at Austin, Austin, USA; 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA; 3. Cardio-Oncology Research Unit, Cardiovascular Analytics Group, School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong, China; 4. Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, USA; 5. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; 6. Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandShow moreShow less
144
days
Multi-scale transcriptomic integration reveals LINC00152-high tumor cells promote TGCT progression and T cell exhaustion
Authors
Jian Cao; Fang Zhu; Kongrong Xu; Zhizhong Liu; Lei Chen; Shanshan Lv; Liqing Fan; Jie Guo; Mina Tao; Yanwei Luo; Guoli Li; Hao BoShow moreShow less
Affiliations
1. Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China; 2. NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China; 3. Department of Reproductive Medicine, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; 4. Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, China; 5. Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China; 6. National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, China; 7. Department of Nephrology, Hunan Clinical Research Center for Chronic Kidney Disease, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China; 8. Hunan Engineering Research Center for Prevention, Treatment and Rehabilitation of Kidney Diseases, Changsha, China; 9. Changsha Innovation Center for Integrated Diagnosis and Treatment Technology of Metabolic dysfunction–associated kidney diseases, Changsha, ChinaShow moreShow less
163
days
Primary tumour resection in de novo stage IV breast cancer: considerations from the PRIM-BC trial
Authors
Ahmad Kaviani; Neda Karkeabadi; Borna FarazmandShow moreShow less
Affiliations
1. Centre hospitalier de l’Université de Montréal, Department of Surgery- Surgical Oncology Service, Montreal, Canada; 2. Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 4. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, IranShow moreShow less
184
days
The brain-lung immunotherapy prognostic (BLIP) Score: a novel robust tool for prognostication in non-small cell lung cancer patients with brain metastases
Authors
Marcus Skribek; Maria-Effrosyni Livanou; Ioannis Vathiotis; Viktor Strandman; Axel Thorell; Andreas Koulouris; Konstantinos Syrigos; Simon Ekman; Georgios TsakonasShow moreShow less
Affiliations
1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Medical Unit Head-Neck, Lung, Skin Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; 3. Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece; 4. Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, GreeceShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days